Key thing here is that this isn't envisioning gene therapies, or small molecules, or CED, nothing complex. This sets the stage to test recombinant MANF, now, which we own without a doubt.

I see on Gerald's LinkedIn he's in comms with Dominion. Everyone is going to figure it out and get this ball rolling.